Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Nov;62(5):842–846. doi: 10.1038/bjc.1990.391

Renal function related to different treatment modalities for malignant germ cell tumours.

N Aass 1, S D Fosså 1, M Aas 1, M W Lindegaard 1
PMCID: PMC1971532  PMID: 2173944

Abstract

The renal function was evaluated with 131I-Hippuran clearance in 171 patients with malignant germ cell tumours. Assessments were performed before treatment and at three fixed times afterwards within 5 years. The patients were treated with surgery only (20 patients), infra-diaphragmatic radiotherapy only (median midplane dose 36 Gy) (48 patients), cisplatin-based chemotherapy (total cisplatin dose 500-850 mg) plus surgery (64 patients), cisplatin-based chemotherapy (total cisplatin dose greater than 850 mg) with or without surgery (23 patients) or cisplatin-based chemotherapy (total cisplatin dose 500-850 mg) plus infra-diaphragmatic radiotherapy (16 patients). No renal impairment was observed for patients treated with surgery only. In patients who received radiotherapy no change of the renal function occurred during the first year post-treatment. Three to five years after treatment discontinuation a statistically significant reduction within the normal range was observed in patients who were greater than 40 years at the time of irradiation. Cisplatin-based chemotherapy led to a statistically significant irreversible renal impairment for all the three groups. The greatest reduction was seen in patients who received the highest total cisplatin dose or who were treated with irradiation in addition to chemotherapy. The clinical significance of the observed nephrotoxicity is still unknown.

Full text

PDF
842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVIOLI L. V., LAZOR M. Z., COTLOVE E., BRACE K. C., ANDREWS J. R. Early effects of radiation on renal function in man. Am J Med. 1963 Mar;34:329–337. doi: 10.1016/0002-9343(63)90120-7. [DOI] [PubMed] [Google Scholar]
  2. Aass N., Fosså S. D., Otto F., Ose T. Acute subjective morbidity after cisplatin-based combination chemotherapy in patients with testicular cancer: a prospective study. Radiother Oncol. 1989 Jan;14(1):27–33. doi: 10.1016/0167-8140(89)90005-4. [DOI] [PubMed] [Google Scholar]
  3. Aass N., Fosså S. D., Ous S., Stenwig A. E., Lien H. H., Paus E., Kaalhus O. Prognosis in patients with metastatic non-seminomatous testicular cancer. Radiother Oncol. 1990 Apr;17(4):285–292. doi: 10.1016/0167-8140(90)90002-e. [DOI] [PubMed] [Google Scholar]
  4. Aass N., Kaasa S., Lund E., Kaalhus O., Heier M. S., Fosså S. D. Long-term somatic side-effects and morbidity in testicular cancer patients. Br J Cancer. 1990 Jan;61(1):151–155. doi: 10.1038/bjc.1990.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Birkhead B. M., Dobbs C. E., Beard M. F., Tyson J. W., Fuller E. A. Assessment of renal function following irradiation of the intact spleen for Hodgkin disease. Radiology. 1979 Feb;130(2):473–475. doi: 10.1148/130.2.473. [DOI] [PubMed] [Google Scholar]
  6. Daugaard G., Abildgaard U. Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol. 1989;25(1):1–9. doi: 10.1007/BF00694330. [DOI] [PubMed] [Google Scholar]
  7. Daugaard G., Rossing N., Rørth M. Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. Cancer Chemother Pharmacol. 1988;21(2):163–167. doi: 10.1007/BF00257365. [DOI] [PubMed] [Google Scholar]
  8. Dentino M., Luft F. C., Yum M. N., Williams S. D., Einhorn L. H. Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer. 1978 Apr;41(4):1274–1281. doi: 10.1002/1097-0142(197804)41:4<1274::aid-cncr2820410410>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  9. Donohue J. P., Rowland R. G. Complications of retroperitoneal lymph node dissection. J Urol. 1981 Mar;125(3):338–340. doi: 10.1016/s0022-5347(17)55029-6. [DOI] [PubMed] [Google Scholar]
  10. Duncan W., Munro A. J. The management of testicular seminoma: Edinburgh 1970-1981. Br J Cancer. 1987 Apr;55(4):443–448. doi: 10.1038/bjc.1987.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fjeldborg P., Sørensen J., Helkjaer P. E. The long-term effect of cisplatin on renal function. Cancer. 1986 Nov 15;58(10):2214–2217. doi: 10.1002/1097-0142(19861115)58:10<2214::aid-cncr2820581009>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  12. Fosså S. D., Aass N., Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):383–388. doi: 10.1016/0360-3016(89)90334-9. [DOI] [PubMed] [Google Scholar]
  13. Fosså S. D., Borge L., Aass N., Johannessen N. B., Stenwig A. E., Kaalhus O. The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol. 1987 Jul;5(7):1071–1077. doi: 10.1200/JCO.1987.5.7.1071. [DOI] [PubMed] [Google Scholar]
  14. Groth S., Nielsen H., Sørensen J. B., Christensen A. B., Pedersen A. G., Rørth M. Acute and long-term nephrotoxicity of cis-platinum in man. Cancer Chemother Pharmacol. 1986;17(2):191–196. doi: 10.1007/BF00306754. [DOI] [PubMed] [Google Scholar]
  15. Hamilton C. R., Bliss J. M., Horwich A. The late effects of cis-platinum on renal function. Eur J Cancer Clin Oncol. 1989 Feb;25(2):185–189. doi: 10.1016/0277-5379(89)90006-0. [DOI] [PubMed] [Google Scholar]
  16. Hansen S. W., Groth S., Daugaard G., Rossing N., Rørth M. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer. J Clin Oncol. 1988 Nov;6(11):1728–1731. doi: 10.1200/JCO.1988.6.11.1728. [DOI] [PubMed] [Google Scholar]
  17. Kim T. H., Somerville P. J., Freeman C. R. Unilateral radiation nephropathy--the long-term significance. Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2053–2059. doi: 10.1016/0360-3016(84)90202-5. [DOI] [PubMed] [Google Scholar]
  18. LUXTON R. W. Radiation nephritis. A long-term study of 54 patients. Lancet. 1961 Dec 2;2(7214):1221–1224. doi: 10.1016/s0140-6736(61)92590-9. [DOI] [PubMed] [Google Scholar]
  19. Le Bourgeois J. P., Meignan M., Parmentier C., Tubiana M. Renal consequences of irradiation of the spleen in lymphoma patients. Br J Radiol. 1979 Jan;52(613):56–60. doi: 10.1259/0007-1285-52-613-56. [DOI] [PubMed] [Google Scholar]
  20. MacLeod P. M., Tyrell C. J., Keeling D. H. The effect of cisplatin on renal function in patients with testicular tumours. Clin Radiol. 1988 Mar;39(2):190–192. doi: 10.1016/s0009-9260(88)80022-9. [DOI] [PubMed] [Google Scholar]
  21. Meijer S., Sleijfer D. T., Mulder N. H., Sluiter W. J., Marrink J., Koops H. S., Brouwers T. M., Oldhoff J., van der Hem G. K., Mandema E. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer. 1983 Jun 1;51(11):2035–2040. doi: 10.1002/1097-0142(19830601)51:11<2035::aid-cncr2820511113>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  22. Moul J. W., Robertson J. E., George S. L., Paulson D. F., Walther P. J. Complications of therapy for testicular cancer. J Urol. 1989 Dec;142(6):1491–1496. doi: 10.1016/s0022-5347(17)39135-8. [DOI] [PubMed] [Google Scholar]
  23. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  24. Pixberg H. U., Just G. Die Bestimmung des effektiven Nierenplasmastroms mit der 131I-Hippursäure-Ganzkörperclearance. Dtsch Med Wochenschr. 1971 Jan 22;96(4):156–passim. doi: 10.1055/s-0028-1108219. [DOI] [PubMed] [Google Scholar]
  25. Robbins M. E., Robinson M., Rezvani M., Golding S. J., Hopewell J. W. The response of the pig kidney to the combined effects of cisplatin and unilateral renal irradiation. Radiother Oncol. 1988 Mar;11(3):271–278. doi: 10.1016/0167-8140(88)90010-2. [DOI] [PubMed] [Google Scholar]
  26. Safirstein R., Winston J., Goldstein M., Moel D., Dikman S., Guttenplan J. Cisplatin nephrotoxicity. Am J Kidney Dis. 1986 Nov;8(5):356–367. doi: 10.1016/s0272-6386(86)80111-1. [DOI] [PubMed] [Google Scholar]
  27. Stewart F., Bohlken S., Begg A., Bartelink H. Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation. Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):927–933. doi: 10.1016/0360-3016(86)90387-1. [DOI] [PubMed] [Google Scholar]
  28. Whitmore W. F., Jr Surgical treatment of adult germinal testis tumors. Semin Oncol. 1979 Mar;6(1):55–68. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES